Doctors aim to stop pancreatic cancer before it forms

July 22, 2011 By Meredith Cohn

Seeing a chance to stop one of the most deadly kinds of cancer before it forms, doctors at hospitals around the nation are focusing on the common pancreatic cyst.

Up to 20 percent of begins as one of these small, fluid-filled brown lesions. And left to grow unabated, pancreatic cancer kills 95 percent of sufferers within five years.

"We have a wonderful opportunity to intervene at an early stage," Dr. Anne Marie Lennon, an assistant professor and director of a new Johns Hopkins Multidisciplinary Pancreatic Cyst Program. "We can intervene like we do for polyps in the colon. We remove them and prevent cancer."

Hopkins has long been a center for pancreatic and research, along with hospitals in Indiana, Illinois, Massachusetts and elsewhere. But this is the first time Hopkins has dedicated staff to cysts that may become cancer. The program, formed in November, sees about 10 new patients a week.

A study last year published in the found that up to 13 percent of the population has a pancreatic cyst, though most do not become cancerous. Researchers studied patients who had undergone an MRI for a reason besides their pancreas, and such has become the main method of discovering pancreatic cysts.

Doctors don't believe the number of cysts is growing - and they aren't even the biggest source of pancreatic cancer, which is less common than many other cancers. There are about 43,000 cases a year nationwide, compared to more than 200,000 cases each of breast, prostate and .

But pancreatic cancer is among the most deadly, taking about 36,800 lives annually, according to the , and spotting it early is the only chance for a cure.

Paula Rhines is one of the Hopkins center's success stories. The 41-year-old sales representative, who lives in Fort Lauderdale, Fla., recently had an early removed at Hopkins.

It was discovered during screening before Rhines had her gallbladder removed in 2006. Doctors in Florida watched the cyst over the years, and when it started growing they still didn't think it was dangerous. They advised her to seek a second opinion.

After a Web search, she picked Hopkins, where doctors did a round of tests similar to the ones she'd had in Florida, including a CT scan, MRI, endoscopic ultrasound and biopsy.

But the Hopkins team found the results concerning and recommended surgery "sooner rather than later," Rhines said. In March, she had a 7{-hour surgery called a Whipple, or a pancreaticoduodenectomy, in which the head of the pancreas and the tumor were removed, as well as the gallbladder, common bile duct and part of the small intestine.

After the surgery, the lab confirmed the cyst was a type that grows within the pancreatic ducts and often develops into invasive pancreatic cancer.

"I feel like someone is looking after me," she said. "This would have progressed into something not good, but they took care of things before it became too late."

Though she's still a bit fatigued, she's now back to work, taking just an occasional Advil and expecting nothing more than a follow-up visit or two a year. Fatigue and trouble eating are the most common complaints after surgery, though they ease over time, said Dr. Christopher L. Wolfgang, an associate professor of surgery and oncology at Hopkins.

He and Lennon said Rhines had pancreatitis after the gallbladder surgery, or inflammation of the pancreas, a gland housed behind the stomach that releases insulin to regulate blood sugar and digestive enzymes to help digest and absorb food.

Sometimes pancreatitis is caused by a cyst or leads to one. Those caused by the condition are often pseudocysts, which are benign pockets of fluid that don't normally have to be removed. But those that can cause pancreatitis, like Rhines', are known to become cancerous.

Those with pancreatitis need to be screened and considered for major surgery, the only method of removing the cysts, the doctors say.

But screening isn't for everyone, Wolfgang said. The cost of all that screening and the potential for unnecessary surgery is too great. For now, those who discover a cyst inadvertently should be evaluated. At Hopkins that would include seeing a team including gastroenterologists, surgeons, radiologists, pathologists and others in determining treatment.

There are guidelines for treatment of some of the more dangerous cysts, such as Rhines', developed by an international group of specialists, which included Wolfgang. The group is about to release a revised set, but the doctor says they still recommend the invasive surgery to ensure cancer - and the potential for the ailment - are cut out.

Those who are found to have cancer also generally undergo chemotherapy. They need regular screening because the chance of recurrence is high, Wolfgang said.

For now, there is no precise way to determine exactly who needs surgery, said Dr. C. Max Schmidt, an associate professor at Indiana University and director of the 6-year-old Pancreatic Cyst & Cancer Early Detection Center, which sees 1,000 patients a year.

Researchers are investigating a genetic marker that would indicate a person's likelihood of developing pancreatic cancer, as is done with breast cancer. For now, Schmidt said he ranks patients based on the available tests. Those with low risk are monitored, and those with high risk are offered surgery.

He said those with certain cysts and those who have a family history of the cancer fall in the high-risk category. "We have two opportunities to cure or prevent cancer," he said of those patients.

Schmidt said he launched a new website called in an effort to reach people with symptoms or family history or who inadvertently discover a cyst so they get to a specialist. Symptoms include abdominal pain, nausea, vomiting and diarrhea. Sometimes, patients have yellowing skin or eyes because the bile duct is obstructed.

There still are few clinics like Indiana's and Hopkins', though more university-linked hospitals are developing multidisciplinary programs to better assess cysts, Schmidt said.

"There has been so very little hope with this cancer, and that's the message that has been sent across the airwaves," he said. "And unfortunately, there really hasn't been well-coordinated screening across the country. But there is hope for these patients if we reach them and intervene."


-They are little fluid-filled brown lesions in the of up to 13 percent of people

-Most are discovered through CT scans or MRIs for another purpose and are benign

-Up to 20 percent of pancreatic cancer begins as a cyst, and unabated the disease kills 95 percent of sufferers in five years

-Surgery for precancerous cysts and early cancerous tumors can cure the disease

Explore further: Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts


Related Stories

Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts

July 20, 2011
Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts. The test may eventually help some patients avoid needless surgery to remove the harmless variety. A report ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.